» Articles » PMID: 11861605

E Protein Function in Lymphocyte Development

Overview
Date 2002 Feb 28
PMID 11861605
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphocytes arise from hematopoietic stem cells through the coordinated action of transcription factors. The E proteins (E12, E47, HEB and E2-2) have emerged as key regulators of both B and T lymphocyte differentiation. This review summarizes the current data and examines the various functions of E proteins and their antagonists, Id2 and Id3, throughout lymphoid maturation. Beyond an established role in B and T lineage commitment, E proteins continue to be essential at subsequent stages of development. E protein activity regulates the expression of surrogate and antigen receptor genes, promotes Ig and TCR rearrangements, and coordinates cell survival and proliferation with developmental progression in response to TCR signaling. Finally, this review also discusses the role of E47 as a tumor suppressor.

Citing Articles

Stabilization of β-Catenin Directs HEB to Limit Thymic Selection.

Tousinas G, Olumide Emmanuel A, Tracy M, Arnovitz S, Friedman D, Papamarcaki T J Immunol. 2024; 213(5):641-650.

PMID: 38958395 PMC: 11333165. DOI: 10.4049/jimmunol.2400160.


Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation.

Tiniakou I, Hsu P, Lopez-Zepeda L, Garipler G, Esteva E, Adams N Sci Immunol. 2024; 9(94):eadi1023.

PMID: 38608038 PMC: 11182672. DOI: 10.1126/sciimmunol.adi1023.


TCF12 regulates the TGF-β/Smad2/3 signaling pathway to accelerate the progression of osteoarthritis by targeting CXCR4.

Zheng H, Fang J, Lu W, Liu Y, Chen S, Huang G J Orthop Translat. 2024; 44:35-46.

PMID: 38235367 PMC: 10792168. DOI: 10.1016/j.jot.2023.11.006.


The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia.

Yang M, Tang Y, Zhu P, Lu H, Wan X, Guo Q Ann Hematol. 2023; 103(9):3385-3398.

PMID: 38148344 DOI: 10.1007/s00277-023-05595-7.


Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.

Jang S, Lee H, Chang E, Kim S, Kim S, Hong I Cancer Immunol Immunother. 2023; 72(8):2757-2768.

PMID: 37165046 PMC: 10361912. DOI: 10.1007/s00262-023-03458-8.